High Costs, Low Margins, and Regulatory Hurdles Hinder Pharma’s Adoption of Advanced Manufacturing Technologies

Benchmark Banner Ad

 

The ongoing drug shortage crisis in the U.S. underscores a critical need for innovation in pharmaceutical manufacturing. As manufacturing issues, outdated technologies, and geopolitical risks contribute to shortages that impact patient care and elevate healthcare costs, the introduction of Advanced Manufacturing Technologies (AMTs) offers a beacon of hope. AMT technologies promise to enhance quality control and reduce production downtime, yet their adoption in generic drug production remains low despite obvious benefits.

Why is the pharmaceutical industry slow to adopt technologies that could revolutionize drug availability and cost?

Mike Tracy, a C-Level Healthcare Operations Strategist, dives into the complexities of integrating Advanced Manufacturing Technologies in drug production. Mike points out that while AMTs can drastically reduce bottlenecks in drug production, the significant initial investment and stringent regulatory landscape pose substantial hurdles.

“Every AMT has a high startup cost and generic drugs have very razor-thin margins to begin with. We’re not talking about a new drug that’s not already out in the market where you’re going to have a high margin and it makes sense to invest millions,” Tracy explains.

Article written by Sonia Gossai

Follow us on social media for the latest updates in B2B!

Image

Latest

Joint Commission 360
Understanding Joint Commission 360 Standards: What They Mean for SPD Teams (Part 2)
March 23, 2026

Healthcare teams today are feeling the pressure to move beyond last-minute compliance and instead build processes that work consistently every day. That shift is especially clear in sterile processing departments (SPDs), where the Joint Commission 360 model is redefining what “survey readiness” really means. With patient safety directly tied to instrument quality—and studies consistently…

Read More
teacher
Building the Next Generation of Educators Through Apprenticeship Pathways and Workforce-Aligned Training
March 23, 2026

Teacher shortages aren’t exactly a new headline—but lately, they’ve started to feel a lot more urgent. In some places, schools have gone years without enough fully trained teachers in the classroom, exposing real flaws in how we prepare and retain educators. Add in the rising cost of becoming a teacher and training models that haven’t…

Read More
Joint Commission 360
Understanding Joint Commission 360 Standards: What They Mean for SPD Teams (Part 1)
March 17, 2026

For a long time, compliance in healthcare was tied to the survey cycle. Now, that model is shifting. With the introduction of Joint Commission 360, organizations are being asked to demonstrate continuous performance—not just preparedness. As patient safety comes under increasing scrutiny, The Joint Commission is moving toward an approach built on real-time data, traceability,…

Read More
university
The Employer University Alignment Journey with Kristen Fox, CEO of Business-Higher Education Forum
March 16, 2026

Across the U.S., the conversation about the value of a college degree is increasingly tied to one central question: Does higher education actually prepare students for the workforce? As artificial intelligence reshapes how work gets done and employers rethink the skills they need, universities are under growing pressure to ensure graduates leave not just…

Read More